InMedica
Name: UAB "InMedica"
Core business: private healthcare services
Date of registration: 18 March 2004
Auditor: UAB „Persense Audit“
Date of bond listing (First North, ISIN LT0000404246): 9 March 2020
Date of bond listing (First North, ISIN LT0000405987): 17 February 2022
Market: Nasdaq Vilnius
Management Board
Nerijus Drobavičius (Chairman), Kęstutis Broniukaitis (Secretary), Ashwin Roy, Josifs Apts, Stella Lapina, Aleksejs Tjurkins
Background Information
“InMedica”, which after the merger with the “MediCA” group now manages the network of 77 clinics, provides diagnostic, outpatient treatment, surgical, dental and other medical services. The “InMedica” group consists of 58 family medicine centres, 6 wide-profile, 7 specialized, 6 walk-in clinics and 3 laboratories.
After the merger, the “InMedica” group now has more than 2800 employees and provides healthcare services to more than 260,000 registered patients. “INVL Baltic Sea Growth Fund”, one of the largest private equity investment funds in the Baltics, owns 45 percent of the shares in the „InMedica“ network through its subsidiary “BSGF Sanus”, 40 percent of the shares is owned by “Repharm”, the largest private medical group in Latvia, and 15 percent – by the company “Litgaja”.
Contact Details
Address: Ozo g. 12A, LT-08200 Vilnius
Telephone/Fax: +370 5 265 1852
E–mail: info@inmedica.lt
Contact person: Kęstutis Broniukaitis (CEO), +370 5 265 1852